Articles from Sunrise

America is grappling with a major sleep health crisis that impacts public health, workplace productivity, and overall quality of life — costing the U.S. economy $411 billion annually (RAND Corporation). A new report from Dreem Health, the leading digital sleep clinic managed by The Sunrise Group, reveals a clear paradox: while 97 percent of Americans recognize the importance of sleep, only 7 percent wake up feeling well-rested daily.

Dreem Health, the leading digital sleep clinic managed by the Sunrise Group, today announced the launch of its women’s health program tailored to support women experiencing sleep issues due to pregnancy, PCOS, perimenopause, menopause, and PMS. Through this program, Dreem Health is empowering women to take control of their sleep health, and overall health, by offering patients a comprehensive approach to diagnosing and treating sleep disorders that are linked to these hormone imbalances.

Sunrise, a leader in proprietary sleep disorder diagnostics technology, today announced plans to bring sleep care to the United States through telehealth services and online-based solutions. The company has acquired Dreem Health, a California-based sleep clinic that offers diagnosis and treatment options for sleep conditions. By pairing Sunrise’s proprietary diagnostic technology with Dreem Health’s partnerships with major insurers and Medicare, the company aims to democratize and accelerate access to sleep care. To date, Sunrise has received more than $35M in capital from investors such as Amazon’s Alexa Fund, Kurma Partners, VIVES Partners, and others.

Sunrise, a key player in sleep diagnostics, has acquired Dreem Health. Launched by sleep tech powerhouse Dreem, Dreem Health stands out for offering easy and covered access to sleep care through its telemedicine platform. By combining an innovative sleep clinic with advanced diagnostic capabilities, this acquisition is set to change the narrative for millions suffering from sleep disorders.

Sunrise, a pioneer in home sleep diagnostics, has welcomed an additional aggregate investment of $6 million from the Alexa Fund and French healthcare investor UI-Investissement (Majycc Innovation Santé), for a total of $24 million raised this year.

Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding. The successful fundraising is led by Kurma Partners and includes the exceptional entry of the European Innovation Council (EIC Fund). The Walloon start-up has also taken an important step by obtaining approval from the European (MDR) and American (FDA) medical authorities. Sunrise hopes to make a real difference to the lives of millions of people around the world who suffer from sleep disorders.

Belgium-based scale-up, Sunrise, announced today the U.S. Food and Drug Administration (FDA) has cleared for use its second generation at-home sleep apnea test that uses artificial intelligence (AI) to aid in the diagnosis of obstructive sleep apnea and sleep-related breathing disorders. The Sunrise team is using a novel way to measure sleep through the bio-signal of Mandibular Jaw Movements (MJM), which has been studied for decades.